Elefant Dov 4
4 · Cellectar Biosciences, Inc. · Filed Jun 8, 2020
Insider Transaction Report
Form 4
Elefant Dov
Chief Financial Officer
Transactions
- Purchase
Common Stock
2020-06-05$1.15/sh+4,348$4,978→ 4,348 total - Purchase
Series H Warrants
2020-06-05$0.01/sh+2,174$22→ 2,174 totalExercise: $1.21From: 2020-06-05Exp: 2025-06-05→ Common Stock (2,174 underlying)